Moleculin Biotech Announces Its Miracle Trial Reports 37% Blinded Complete Remission In Venetoclax-failed R/R AML Patients

Benzinga · 3d ago

https://www.sec.gov/ix?doc=/Archives/edgar/data/1659617/000143774926025167/mbrx20260729_8k.htm